We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Phase 1 trial investigates Ceralasertib's effects as monotherapy in patients with advanced solid malignancies, indicating potential treatment options.
ClinicalTrials.gov, NCT05469919. Registration date: May 18, 2022.
No takes yet. Share an insight, caveat, or question.
Kuboki et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: